QUOTE
BioCryst Pharmaceuticals, Inc. (BCRX)
$
5.00
 $0.27 (5.71%) Sep 01
|
2190 Parkway Lane Drive
,
Birmingham,
AL
35244
,
USA
+1-205-444-4600
http://www.biocryst.com/ |
|
|
| PRICES |
| Open |
Volume |
| 4.84 |
331,200 |
| High |
Low |
| 5.00 |
4.74 |
|
| VALUATIONS |
| Mkt Cap |
Avg Volume |
| 191.65M |
14,600 |
| 52wk High |
52wk Low |
| 12.32 |
4.55 |
|
| RATIOS |
| P/E |
EPS |
| -14.29 |
-0.35 |
| BV |
P/BV |
| 1.21 |
4.13 |
|
| STOCKHOLDERS |
| Dividend |
Yield |
| n/a |
n/a |
| Shares |
Inst Owner |
| 38.33M |
|
|
|
|
|
PERFORMANCE
You need to upgrade your Flash Player
|
|
ANNUAL EARNINGS
You need to upgrade your Flash Player
|
|
QUARTERLY EARNINGS (EPS)
You need to upgrade your Flash Player
|
|
SUMMARIES CALENDARS REPORTS
|
|
| Financial Summary (In millions of USD)
|
| |
2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 |
| Income statement |
| Total Revenue |
$11.16 | - | $0.65 | $0.34 | $0.15 | $6.21 | $71.24 | $56.56 |
| Oprating Income |
$-4.99 | $-18.70 | $-13.68 | $-21.75 | $-27.18 | $-46.98 | $-32.28 | $-27.16 |
| Net Income |
$-4.99 | $-16.93 | $-12.70 | $-21.10 | $-26.10 | $-43.62 | $-29.05 | $-24.73 |
| Balance Sheet |
| Total Assets |
$59.10 | $41.30 | $30.09 | $32.47 | $99.25 | $68.48 | $142.72 | $84.69 |
| Total Equity |
$56.81 | $40.13 | $28.45 | $29.33 | $58.44 | $21.15 | $64.91 | $46.43 |
| Total Liabilities |
$2.28 | $1.17 | $1.65 | $3.13 | $40.81 | $47.33 | $77.81 | $38.26 |
| Cash Flow |
| Oprating |
$-10.16 | $-16.37 | $-11.20 | $-18.15 | $-23.35 | $-15.21 | $-25 | $-20.87 |
| Investing |
$20.38 | $10.26 | $8.37 | $-2.84 | $-11.51 | $-12.49 | $-15.03 | $11.39 |
| Financing |
$0.18 | $0.12 | $0.90 | $21.48 | $55.18 | $2.96 | $66.77 | $0.67 |
| Net Cash Change |
$10.41 | $-5.98 | $-1.93 | $0.49 | $20.32 | $-24.74 | $26.74 | $-8.81 |
|
Earning Call Calender
|
| 2010 | 2009 |
2008 |
2007 |
2006 |
04 February 2010
28 April 2010
05 August 2010
|
06 February 2009
08 May 2009
30 July 2009
29 October 2009
|
04 March 2008
08 May 2008
07 August 2008
31 October 2008
|
09 May 2007
09 August 2007
08 November 2007
|
| |
|
| Earning Call Summary |
Transcripts |
| |
|
Management
|
|
Executive |
Title |
|
Jon P. Stonehouse |
Chief Executive Officer, Director | |
|
Alane Barnes |
General Counsel |
|
Thomas J. Simon |
Interim Chief Medical Officer |
|
William W. Featheringill |
Director |
|
J. Claude Bennett |
President, Chief Operating Officer, Director |
|
David S. McCullough |
Vice President - Strategic Planning and Commercialization |
|
W. James Alexander |
Senior Vice President - Clinical and Regulatory Operations and Chief Medical Officer |
|
Stuart Grant |
Chief Financial Officer, Senior Vice President |
|
Michael A. Darwin |
Vice President, Finance,Chief Financial Officer |
|
Robert Stoner |
Vice President, Human Resources |
|
Elliott Berger, Ph.D. |
Senior Vice President, Regulatory Affairs |
|
|
|
Sources: Data collected by 123jump.com and Ticker.com from company press releases, filings and corporate websites. Market data: BATS Exchange. Inc
